Newsroom

In der weltweit größten Substanz-Repurposing-Bank „ReFrame“ suchen Wissenschaftler nach Medikamenten gegen COVID-19.

News

Innovations based on proven active ingredients, new indications for established drugs – the principle of repurposing has often led to success in medicine. This is why it is also used against SARS-CoV-2: In order to quickly find a drug to treat COVID-19, this international research network is searching for substances that act against SARS-CoV-2 in the world's largest substance repurposing bank "ReFrame". The collection comprises around 14,000 approved drugs as well as active ingredients for which extensive safety data are already available with regard to their use in humans. Several laboratories in the USA, four in the UK and one each in China and Germany are involved in the search. "ReFrame" was established by Scripps Research, California, in 2018 with the support of the Bill & Melinda Gates Foundation.

24.04.2020

TWINCORE

Flagella that protrude from bacterial cells

News

Several whip-like appendages, called the flagella, protrude from the body of bacteria such as Salmonella Typhimurium. It has long been understood that the flagella are responsible for bacterial motility, which enables the directed movement of bacteria towards nutrients or an infection target site. In a recent publication in Nature Communications, researchers from the Centre for Structural Systems Biology (CSSB) in Hamburg and collaborators have demonstrated that flagella also promote bacterial adhesion and host cell invasion. The CSSB is a common initiative by nine northern German research institutions, including the Helmholtz Centre for Infection Research (HZI) in Braunschweig.

24.04.2020

CSSB

Der Leiter der Zentralen Einrichtung für Molekulare Diagnostik (ZEM) im Institut für Pathologie, Dr. Horst Hannig.

News

Außergewöhnliche Situationen bringen die Menschen näher zusammen. Das gilt aktuell in unserer Region. Während sich das Klinikum Braunschweig auf große Herausforderungen einstellt, ist die Hilfsbereitschaft von umliegenden Unternehmen, aber auch Forschungseinrichtungen groß. Eine enorme Unterstützung für den Maximalversorger kommt jetzt vom Helmholtz-Zentrum für Infektionsforschung (HZI) und der Technischen Universität (TU) Braunschweig.

21.04.2020

HZI Campus

Bakterien der Art Pseudomonas aeruginosa sind äußerst widerstandfähig und kommen fast überall vor.

News

Scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have developed a strategy to administer antibacterial agents in a way that makes them many times more effective. Their results give rise to hope in the fight against hospital infections and antibiotic resistance. The study has been published in the international edition of the journal Angewandte Chemie/Applied Chemistry. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig in cooperation with Saarland University.

17.04.2020

HIPS

News

The GSI Helmholtzzentrum für Schwerionenforschung and the FAIR GmbH (GSI/FAIR) uses its research potential and unique infrastructure to contribute to the management of the current corona pandemic. In several areas at GSI/FAIR, scientists are working to provide new insights and technologies that may help to fight the corona virus SARS-CoV-2. In cooperation with the Helmholtz Centre for Infection Research (HZI) in Braunschweig, methods for virus inactivation are being tested. These inactivated viruses are used for vaccine development. To this aim, the accelerators and laboratories on the Darmstadt campus are also being used. The laboratory is operational, while strictly abiding to safety regulations.

16.04.2020

HZI Campus

News

Researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Forschungszentrum Jülich (FZJ) are modelling the further course of the epidemic, taking into account various scenarios for relaxing the ban on contact and making recommendations.

14.04.2020

HZI Campus

Back to the first page
...
65
66
67
68
...
150

HZI in the media

tools.” – Dr. Anya Sharma, Virologist at the Helmholtz Centre for Infection Research.

Looking Ahead: The Long-Term Implications of

08.01.2026

ARCHYDE

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026

News Medical

... basierte Infektionsforschung (HIRI) in Würzburg nachweisen. Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung ...

07.01.2026

DeutschesGesundheitsPortal

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026

Trading View

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026

Biermann Medizin

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025

Tagesschau

Erkrankungen. Eine Arbeitsgruppe des TWINCORE Helmholtz Zentrum für Infektionsforschung ( HZI ) und der Medizinischen Hochschule Hannover ( ...

30.12.2025

Deutsches Ärzteblatt

Forschungsteam um Tobias Gulder, Abteilungsleiter am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), ist es ...

29.12.2025

Biermann Medizin

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

29.12.2025

Das PTA Magazin

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Forschende vom Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

17.12.2025

Verband Deutscher Biologen e.V.

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.